Market Research Report Store Cachexia-Global API Manufacturers, Marketed and Ph | Page 2

• Coverage of global patent coverage and detailed commentaries on the US patent challenges. • Graphical representation of investigational products for patent expiry and market exclusivities across the globe. • Product profiles for marketed products for Cachexia with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details. • Coverage of API Manufacturers for Cachexia drugs in the United States, Europe and Asian Regions with location details. • Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Cachexia drugs. • Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Cachexia drugs. • Coverage of Cachexia Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress. • Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs. • Key discontinued Marketed products. • Global Sales Figure to 2018. Reasons to buy • Evaluate the marketing status and exclusivity details of Cachexia key products to exploit opportunities for generic drug development opportunities. • Identify and understand important and diverse types of therapeutics under Phase III development for Cachexia. • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Cachexia. • API intelligence over marketed drugs forCachexiaand gaining primary intelligence over active ingredients manufacturers across the globe. • API intelligence over leading Phase III Pipeline drugs. • Develop and designstrategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope. • Understanding the scope of the Phase III Drugs with nil regulatory filings.